On January 6, 2020, OncoSec Medical Incorporated issued a letter to its shareholders. In the letter, the Company stated that both the independent proxy advisory firms, Institutional Shareholder Services Inc. (ISS) and Glass, Lewis & Co., have recommended that the shareholders vote for the CGP/Sirtex Transaction on the Company’s proxy card, and in their independent analyses, support what the Company has said since announcing the CGP/Sirtex Transaction in October 2019. The Company added that over the past several weeks Alpha Holdings, Inc. has been waging a campaign of misinformation in an effort to derail the CGP/Sirtex Transaction.